血脑屏障穿透肽的研究进展OA
Research advances in blood-brain barrier-penetrating peptides
随着多肽药物逐步进入市场,细胞穿透肽因其低毒性、高度靶标特异性和耐受性而备受关注.靶向中枢神经的细胞穿透肽能够高效携带治疗性药物穿越血脑屏障,为阿尔茨海默病、帕金森病、脑肿瘤及病毒性感染等中枢神经系统疾病的治疗开辟了新途径.该文综述了血脑屏障穿透肽的特点、入胞机制及其在中枢神经系统疾病治疗中的应用研究进展.
As more peptide drugs are increasingly entering the market,cell-penetrating peptides(CPPs)have attracted much attention due to their low toxicity,high target specificity and tolerability.CPPs targeting the central nervous system are able to transport therapeutic cargoes across the blood-brain barrier(BBB),offering novel strategies for treating the central nervous system(CNS)disorders,including Alzheimer's disease,Parkinson's disease,brain tumors,and neurotropic viral infections.This review summarizes the structural characteristics of blood-brain barrier-penetrating peptides,elucidates their mechanisms of cellular internalization,and outlines their applications in the treatment of CNS diseases.
吴灵莉;贾彩云;肖鹤
军事科学院军事医学研究院国家安全特需药物全国重点实验室,北京 100850||河南大学抗体药物开发技术国家地方联合工程实验室,河南 开封 475004河南大学抗体药物开发技术国家地方联合工程实验室,河南 开封 475004军事科学院军事医学研究院国家安全特需药物全国重点实验室,北京 100850
医药卫生
多肽血脑屏障中枢神经系统疾病
peptidesblood-brain barriercentral nervous system disorders
《军事医学》 2026 (2)
136-141,6
国家自然科学基金面上项目(31771010)
评论